7 independently checked trend briefs about this subject, newest first.
headlinez.news detected 7 source-qualified news clusters connected to Diagnostics between July 3, 2026 and July 29, 2026. They span 2 newsroom categories and average 10.7 independent sources per brief.
This hub includes only briefs supported by at least four sources and passed by the site's verification gate. Raw or weak detections may exist but are excluded here. Topic matching is based on the entities and themes recorded with each brief; open a card to inspect its source links, publication time, verification label and velocity history. Read the methodology and editorial policy for the full rules.
Diagnostic advancements in blood-based testing are shifting the Alzheimer's detection timeline, enabling the identification of risks years before symptoms.
New clinical studies suggest blood-based testing can identify Alzheimer’s disease risk in healthy adults up to a decade before symptom onset.
Abbott Laboratories reports second-quarter growth and elevates its full-year earnings forecast following strong performance across multiple sectors.
New clinical studies indicate blood tests may identify Alzheimer's disease risks in healthy individuals years before symptoms appear.
A new non-invasive brush biopsy test is making headlines for its ability to detect oral cancers within one hour with over 95% accuracy.
Medical reports suggest millions of patients may receive incomplete cardiovascular risk assessments by relying on standard LDL cholesterol testing.
New diagnostic blood tests for Alzheimer’s are moving from clinical research to public awareness, sparking debate over early detection and patient anxiety.